Upregulation of fibrinolysis by adenovirus-mediated transfer of urokinase-type plasminogen activator genes to lung cells in vitro and in vivo

Human Gene Therapy

Volumn 10, Issue 2, 1999, Pages 215-222

  Hattori, Noboru ^a   Sisson, Thomas H ^a   Xu, Yin ^a   Simon, Richard H ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; FIBRIN; PLASMINOGEN ACTIVATOR; UROKINASE;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; EPITHELIUM CELL; EXPRESSION VECTOR; EXTRACELLULAR MATRIX; FIBRINOLYSIS; GENETIC REGULATION; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; LUNG FIBROSIS; LUNG LAVAGE; MOUSE; NONHUMAN; TRACHEA; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; CELL LINE; FIBRINOLYSIS; GENE TRANSFER TECHNIQUES; HUMANS; LUNG; MALE; MICE; MICE, INBRED C57BL; RECOMBINATION, GENETIC; TISSUE PLASMINOGEN ACTIVATOR; UP-REGULATION;

EID: 0033585441     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950019002     Document Type: Article

References (46)

1. BACHOFEN, A., and WEIBEL, E.R. (1977). Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. Am. Rev. Respir. Dis. 116, 589-615.
2. BARAZZONE, C., BELIN, D., PIGUET, P.P., VASSALLI, J.D., and SAPPINO, A.P. (1996). Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury. J. Clin. Invest. 98, 2666-2673.
3. BASSET, F., FERRANS, V.J., SOLER, P., TAKEMURA, T., FUKUDA, Y., and CRYSTAL, R.G. (1986). Intraluminal fibrosis in interstitial lung disorders. Am. J. Pathol. 122, 443-461.
4. BERTOZZI, P., ASTEDT, B., ZENZIUS, L., LYNCH, K., LEMAIRE, F., ZAPOL, W., and CHAPMAN, H.A., JR. (1990). Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N. Engl. J. Med. 322, 890-897.
5. BLASI, F., and VERDE, P. (1990). Urokinase-dependent cell surface proteolysis and cancer. Semin. Cancer Biol. 1, 117-126.
6. CARMELIET, P., SCHOONJANS, L., KIECKENS, L., REAM, B., DEGEN, J., BRONSON, R., DE VOS, R., VAN DEN OORD, J.J., COLLEN, D., and MULLIGAN, R.C. (1994). Physiological consequences of loss of plasminogen activator gene function in mice. Nature (London) 368, 419-424.
7. CHAPMAN, H.A., ALLEN, C.L., and STONE, O.L. (1986). Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease. Am. Rev. Respir. Dis. 133, 437-443.
8. COLLEN, D., and LIJNEN, H.R. (1991). Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 78, 3114-3124.
9. EITZMAN, D.T., McCOY, R.D., ZHENG, X., FAY, W.P., SHEN, T., GINSBURG, D., and SIMON, R.H. (1996). Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J. Clin. Invest. 97, 232-237.
10. ELLIS, V., BEHRENDT, N., and DANO, K. (1991). Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor. J. Biol. Chem. 266, 12752-12758.
11. FUKUDA, Y., ISHIZAKI, M., MASUDA, Y., KIMURA, G., KAWANAMI, O., and MASUGI, Y. (1987). The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage. Am. J. Pathol. 126, 171-182.
12. GROSS, T.J., SIMON, R.H., and SITRIN, R.G. (1990). Expression of urokinase-type plasminogen activator by rat pulmonary alveolar epithelial cells. Am. J. Respir. Cell. Mol. Biol. 3, 449-456.
13. GROSS, T.J., SIMON, R.H., and SITRIN, R.G. (1992). Tissue factor procoagulant expression by rat alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 6, 397-403.
14. HART, D.A., WHIDDEN, P., GREEN, F., HENKIN, J., and WOODS, D.E. (1994). Partial reversal of established bleomycin-induced pulmonary fibrosis by rh-urokinase in a rat model. Clin. Invest. Med. 17, 69-76.
15. HASDAY, J.L., BACHWICH, P.R., LYNCH, J.P., and SITRIN, R.G. (1988). Procoagulant and plasminogen activator activities of bronchoalveolar fluid in patients with pulmonary sarcoidosis. Exp. Lung Res. 14, 261-278.
16. HOYLAERTS, M., RIJKEN, D.C., LIJNEN, H.R., and COLLEN, D. (1982). Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J. Biol. Chem. 257, 2912-2919.
17. IDELL, S., JAMES, K.K., GILLIES, C., FAIR, D.S., and THRALL, R.S. (1989a). Abnormalities of pathways of fibrin turnover in lung lavage of rats with oleic acid and bleomycin-induced lung injury support alveolar fibrin deposition. Am. J. Pathol. 135, 387-399.
18. IDELL, S., JAMES, K.K., LEVIN, E.G., SCHWARTZ, B.S., MANCHANDA, N., MAUNDER, R.J., MARTIN, T.R., MCLARTY, J., and FAIR, D.S. (1989b). Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J. Clin. Invest. 84, 695-705.
19. IDELL, S., KOENIG, K.B., FAIR, D.S., MARTIN, T.R., MCLARTY, J., and MAUNDER, R.J. (1991). Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome. Am. J. Physiol. 261, L240-L248.
20. IDELL, S., JAMES, K.K., and COALSON, J.J. (1992). Fibrinolytic activity in bronchoalveolar lavage of baboons with diffuse alveolar damage: trends in two forms of lung injury. Crit. Care Med. 20, 1431-1440.
21. IDELL, S., KUMAR, A., KOENIG, K.B., and COALSON, J.J. (1994). Pathways of fibrin turnover in lavage of premature baboons with hyperoxic lung injury. Am. J. Respir. Crit. Care Med. 149, 767-775.
22. IKEDA, T., HIROSE, N., KOTO, H., HIRANO, H., and SHIGEMATSU, N. (1989). Fibrin deposition and fibrinolysis in the pathogenesis of pulmonary Fibrosis. Nippon Kyobu Shikkan Gakkai Zasshi 27, 448-451.
23. JONES, A.W., and REEVE, N.L. (1978). Ultrastructural study of bleomycin-induced pulmonary changes in mice. J. Pathol. 124, 227-233.
24. KAPLAN, J.M., PENNINGTON, S.I., ST. GEORGE, J.A., WOODWORTH, L.A., FASSENDER, A., MARSHALL, J., CHENG, S.H., WADSWORTH, S.C., GREGORY, R.J., and SMITH, A.E. (1998). Potentiation of gene transfer to the mouse lung by complexes of adenovirus vector and polycations improves therapeutic potential. Hum. Gene Ther. 9, 1469-1479.
25. KESKI-OJA, J., BLASI, F., LEOF, E.B., and MOSES, H.L. (1988). Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-beta. J. Cell. Biol. 106, 451-459.
26. KORST, R.J., BEWIG, B., and CRYSTAL, R.G. (1995). In vitro and in vivo transfer and expression of human surfactant SP-A- and SP-B-associated protein cDNAs mediated by replication-deficient, recombinant adenoviral vectors. Hum. Gene Ther. 6, 277-287.
27. KOTANI, I., SATO, A., HAYAKAWA, H., URANO, T., TAKADA, Y., and TAKADA, A. (1995). Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis. Thromb. Res. 77, 493-504.
28. KUHN, C., BOLDT, J., KING, T.J., CROUCH, E., VARTIO, T., and MCDONALD, J.A. (1989). An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am. Rev. Respir. Dis. 140, 1693-1703.
29. LIJNEN, H.R., VAN HOEF, B., and COLLEN, D. (1996). Characterization of the murine plasminogen/urokinase-type plasminogen-activator systm. Eur. J. Biochem. 241, 840-848.
30. MIN, H.Y., SEMNANI, R., MIZUKAMI, I.F., WATT, K., TODD, R.F., III, and LIU, D.Y. (1992). cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator. J. Immunol. 148, 3636-3642.
31. NANBU, R., MENOUD, P.A., and NAGAMINE, Y. (1994). Multiple instability-regulating sites in the 3′ untranslated region of the urokinase-type plasminogen activator mRNA. Mol. Cell. Biol. 14, 4920-4928.
32. OLMAN, M.A., MACKMAN, N., GLADSON, C.L., MOSER, K.M., and LOSKUTOFF, D.J. (1995). Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse. J. Clin. Invest. 96, 1621-1630.
33. PLOW, E.F., FREANEY, D.E., PLESCIA, J., and MILES, L.A. (1986). The plasminogen system and cell surfaces: Evidence for plasminogen and urokinase receptors on the same cell type. J. Cell Biol. 103, 2411-2420.
34. POWELL JONES, C.H. (1988). Rapid SDS-PAGE zymography of plasminogen activators. Thromb. Res. 49, 299-302.
35. SCHAFER, B.M., MAIER, K., EICKHOFF, U., TODD, R.F., and KRAMER, M.D. (1994). Plasminogen activation in healing human wounds. Am. J. Pathol. 144, 1269-1280.
36. SIMMONS, W.L., RIVERA, K.E., CURIEL, D.T., WILLIAMS, W.F., and OLMAN, M.A. (1998). Adenovirally mediated gene transfer of functional human tissue-type plasminogen activator to murine lungs. Am. J. Respir. Cell Mol. Biol. 18, 307-314.
37. SIMON, R.H., GROSS, T.J., EDWARDS, J.A., and SITRIN, R.G. (1992). Fibrin degradation by rat pulmonary alveolar epithelial cells. Am. J. Physiol. 262, L482-L488.
38. SITRIN, R.G., KALTREIDER, H., ANSFIELD, M., and WEBSTER, R. (1983). Procoagulant activity of rabbit alveolar macrophages. Am. Rev. Respir. Dis. 128, 282-287.
39. TKACHUK, V., STEPANOVA, V., LITTLE, P.J., and BOBIK, A. (1996). Regulation and role of urokinase plasminogen activator in vascular remodelling. Clin. Exp. Pharm. Physiol. 23, 759-765.
40. TS'AO, C.H., WARD, W.F., and PORT, C.D. (1983). Radiation injury in rat lung. III. Plasminogen activator and fibrinolytic inhibitor activities. Radiat. Res. 96, 301-308.
41. VASSALLI, J.D., BACCINO, D., and BELIN, D. (1985). A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase. J. Cell Biol. 100, 86-92.
42. VISCARDI, R.M., BRODERICK, K., SUN, C.C., YALE-LOEHR, A.J., HESSAMFAR, A., TACIAK, V., BURKE, K.C., KOENIG, K.B., and IDELL, S. (1992). Disordered pathways of fibrin turnover in lung lavage of premature infants with respiratory distress syndrome. Am. Rev. Respir. Dis. 146, 492-499.
43. WEITZ, J.I., LESLIE, B., and GINSBERG, J. (1991). Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis. J. Clin. Invest. 87, 1082-1090.
44. YAMAMOTO, K., and LOSKUTOFF, D.J. (1996). Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. J. Clin. Invest. 97, 2440-2451.
45. YANG, Y., TRINCHIERI, G., and WILSON, J.M. (1995). Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nature Med. 1, 890-893.
46. YANG, Y., GREENOUGH, K., and WILSON, J.M. (1996). Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver. Gene Ther. 3, 412-420.